Description: Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China. Its products include crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadra Heparin calcium raw materials, nadroparin calcium injections, and dalteparin sodium raw materials and injections. The company was founded in 2000 and is based in Shijiazhuang, China.
Home Page: www.heparin.cn
Zhengding County High-tech Ind Dev Zone
Shijiazhuang,
050800
China
Phone:
83 311 8919 0181
Officers
| Name | Title |
|---|---|
| Mr. Xiaodong Gao | GM & Chairman |
| Mr. Wang Jun | CFO & Deputy GM |
| Ms. Zhiying Zhang | Deputy GM & Non-Independent Director |
| Ms. Yunxia Sun | Deputy GM & Non-Independent Director |
| Ms. Qing Zhang | Deputy Gen. Mang. |
Exchange: SHE
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 55.6 |
| Price-to-Book MRQ: | 1.8383 |
| Price-to-Sales TTM: | 2.2051 |
| IPO Date: | 2011-08-19 |
| Fiscal Year End: | December |
| Full Time Employees: | 1306 |